Opportunity
Alberta Purchasing #2026RSS0081 / AB-2026-06470
University of Calgary award for Agilent Seahorse XF metabolic analysis instruments
Posted
September 23, 2026
Identifier
2026RSS0081 / AB-2026-06470
NAICS
423490
The University of Calgary is acquiring Agilent Seahorse instruments for platelet bioenergetics research. - Government buyer: University of Calgary, Hemostasis and Thrombosis Platelet Biology Laboratory. - Awarded supplier and OEM: Agilent Technologies Canada Inc, for Agilent Seahorse instruments. - Products requested: - Agilent Seahorse XF HS Mini Analyzer — quantity and part number not specified. - Agilent Seahorse XF Analyzer — quantity and part number not specified. - Research use: Supports platelet bioenergetics studies, including research related to pre-eclampsia, pediatric sickle cell disease, and rheumatoid arthritis. - Notable requirement: The University states that no reasonable alternative meets the combined scientific, technical, and operational requirements. - Award information: The stated award amount is 149,871; currency is not specified in the provided information. Delivery is in Calgary, Alberta, Canada.
Description
The University of Calgary requires Agilent Seahorse XF metabolic analysis instrumentation for ongoing platelet bioenergetics research in its Hemostasis and Thrombosis Platelet Biology Laboratory. The equipment will support studies of platelet metabolism and thrombotic risk in patient cohorts, including pre-eclampsia, pediatric sickle cell disease, and rheumatoid arthritis. Research requires controlled evaluation of metabolic responses in living platelet samples and reproducible longitudinal data. The University states that no reasonable alternative meets all mandatory scientific, technical, and operational requirements concurrently.